CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Medical Officer sold 11,292 shares at an average $1.72 ($19,421)
- 4 Open-market sale Chief Executive Officer sold 31,805 shares at an average $1.72 ($54,791)
- 4 Open-market sale Chief Operating Officer sold 3,584 shares at $1.69 ($6,071)
- 4 Open-market sale Chief Patient Supply Officer sold 1,100 shares at $1.69 ($1,863)
- 4 Open-market sale Chief Medical Officer sold 876 shares at $1.69 ($1,484)
- 4 Open-market sale Chief Executive Officer sold 5,073 shares at $1.69 ($8,594)
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 2,536 shares at $1.97 ($4,993)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Patient Supply Officer sold 2,983 shares at $1.77 ($5,290)
- 4 Open-market sale Chief Commercial Officer sold 21,040 shares at $1.77 ($37,314)
- 4 Open-market sale Chief Patient Supply Officer sold 1,973 shares at $1.68 ($3,311)
- 4 Derivatives Options or other derivatives
Page 12 of 41 · 808 filings